Dr. Levine's areas of interest include clinical trials in breast cancer and venous thromboembolism.
- Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S and Willan A. "A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis". New England Journal of Medicine 334:677-681, 1996.
- Levine MN, Bramwell VH, Pritchard KI, Norris BD, Shepherd LE, Abu-Zahra H, Findlay B, Warr D, Bowman D, Myles J, Arnold A, Vandenberg T, MacKenzie R, Robert J, Ottaway J, Burnell M, Williams CK, Tu D for the National Cancer Institute of Canada Clinical Trials Group. "Randomized trial of intensive cyclophosphamide, epirubicin and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer". Journal of Clinical Oncology 16:2651-2658, 1998.
- Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AJ, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, and Gent M, for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT)Investigators. "Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer". New England Journal of Medicine 349:146-153, 2003.
Search for publications for Dr. Levine on PubMed